Takeuchi, Jun
Ota, Hikaru
Nakano, Yuyako
Horiguchi, Etsuyo
Taki, Yosuke
Ito, Yasuki
Terasaki, Hiroko
Nishiguchi, Koji M
Kataoka, Keiko
Funding for this research was provided by:
Japan Society for the Promotion of Science (KAKENHI JP 18K16953)
Article History
Received: 7 December 2022
Revised: 5 February 2023
Accepted: 25 February 2023
First Online: 8 March 2023
Declarations
:
: This retrospective study involving human participants was in accordance with the ethical standards of the institutional and national research committee, and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board of the Nagoya University Graduate School of Medicine (2021–0339) and Kyorin University Graduate School of Medicine (1903 approved this study.
: Hiroko Terasaki received non-financial research support from Carl Zeiss related to OCT angiography. Jun Takeuchi received honoraria for lectures from Novartis, Santen, Bayer, Senju, and Chugai. Hikaru Ota received honoraria for lectures from Novartis. Yasuki Ito received honoraria for lectures from Aichi Ophthalmologists Association, Bayer, Canon, ZEISS, Kowa, Novartis, Okazaki City Medical Association, Pfizer, and Santen. Hiroko Terasaki received grants and honoraria for lectures from Otsuka, Kowa, Santen, Senju, Sanofi, Alcon, Novartis, ROHTO, Wakamoto. She received grants and consulting fees from Bayer and honoraria for lectures from HOYA and Johnson & Johnson. Koji M Nishiguchi received grants from Takara bio, Takeda pharmaceutical, JCR Pharma, Alcon, and Bayer, and honoraria for lectures from Novartis, Santen, Chugai Pharma, Kowa, Senju, Otsuka, and Wakamoto. He has a patent related to a single AAV vector. Keiko Kataoka received honoraria for lectures from Chugai, Novartis, Santen, Bayer, Senju, Boehringer Ingelheim, and Otsuka. The other authors have no conflicting interests to disclose.